Results 1 to 10 of about 298,746 (351)

Global epidemiology of vasculitis

open access: yesNature Reviews Rheumatology, 2021
The many forms of vasculitis are characterized by inflammation of blood vessels, leading to potentially long-term sequelae including vision loss, aneurysm formation and kidney failure. Accurate estimation of the incidence and prevalence has been hampered
Richard A Watts   +2 more
exaly   +2 more sources

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

open access: yesArthritis and Rheumatology, 2021
To provide evidence‐based recommendations and expert guidance for the management of antineutrophil cytoplasmic antibody–associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic ...
Sharon A Chung   +2 more
exaly   +3 more sources

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

open access: yesAnnals of the Rheumatic Diseases, 2018
Christian Dejaco   +2 more
exaly   +2 more sources

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

open access: yesAnnals of the Rheumatic Diseases, 2016
Max Yates   +2 more
exaly   +2 more sources

EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

open access: yesAnnals of the Rheumatic Diseases, 2023
Background Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials have been published that have the potential to change ...
B. Hellmich   +26 more
semanticscholar   +1 more source

Avacopan for the Treatment of ANCA-Associated Vasculitis.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND The C5a receptor inhibitor avacopan is being studied for the treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. METHODS In this randomized, controlled trial, we assigned patients with ANCA-associated vasculitis in
D. Jayne   +3 more
semanticscholar   +2 more sources

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis

open access: yesArthritis & Rheumatology, 2021
To provide evidence‐based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis.
M. Maz   +31 more
semanticscholar   +1 more source

Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders

open access: yesBMC Women's Health, 2021
Background Consequences of long-term B cell depletion with rituximab are not well understood. We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment, distinct from previously described vulvovaginal pyoderma ...
Laura Yockey   +8 more
doaj   +1 more source

Diagnostic delays in vasculitis and factors associated with time to diagnosis

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Patients with vasculitis, a set of rare diseases, encounter delays in obtaining an accurate diagnosis which can lead to substantial morbidity and increased mortality.
Antoine G. Sreih   +9 more
doaj   +1 more source

A sore red eye with systemic involvement [PDF]

open access: yes, 2010
The study of happiness has long been a playground for philosophical speculation. By lack of empirical measures of happiness, it was not possible to check propositions about the matter.
Lightman, SL   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy